Prognostic factors of mortality rate in patients with spontaneous intracerebral hemorrhage

Authors

Keywords:

INTRACEREBRAL HEMORRHAGE, GLASGOW COMA SCALE, MORTALITY, PROGNOSTIC FACTOR

Abstract

Introduction: spontaneous intracerebral hemorrhage (ICH) is considered, among all strokes, the one having the most devastating effect, the estimated mortality rate per month ranges between 35 and 52 %.

Objective: to determine the factors that influence 30-day mortality rate in patients with Spontaneous Intracerebral Hemorrhage.

Methods: a cross-sectional, analytical, observational study conducted at Dr. Carlos Juan Finlay Military Hospital over a period of 3 years (2017 to 2019). The target group comprised 75 patients. Demographic, clinical and tomographic variables were studied. Descriptive statistics was applied: absolute and relative frequency, arithmetic mean and standard deviation; along with inferential statistics: logistic regression using the Odds Ratio with a 95 % confidence interval, for a positive significance on p <0.05.

Results: the age group from 48 to 75 years prevailed with 45 patients (60 %), male sex 44 patients (58. 7%), and white race 33 (44 %). Hypertension predominated as the main antecedent in 61 patients (81. 3 %). Significantly positive results were obtained for ages over 80 (p = 0,001); the severe state according to Glasgow Coma Scale (p = 0,005); the presence of ventricular extension (p = 0,001) and treatment with oral anticoagulants (p = 0.023).

Conclusions: intracerebral hemorrhage is evidence for extensive mortality rates. People over 80 years old, treated with oral anticoagulants have a higher risk of death due to this entity. Ventricular extension and a low score on the Glasgow Coma Scale worsen the prognosis.

Downloads

Download data is not yet available.

References

. 1. Macías Ruíz V, Cordero Pérez MB, Vásquez Cedeño D, Saltos Mata F. Factores Asociados a la Mortalidad de la Hemorragia Cerebral Intraparenquimatosa Espontánea en Pacientes Mayores de 50 Años de Edad que Acudieron al Hospital Teodoro Maldonado Carbo Durante el Año 2017. Rev. Ecuat. Neurol. [internet] 2019 [citado 13/12/2019]; 28 (1): 10-15. Disponible en: http://scielo.senescyt.gob.ec/scielo.php?script=sci_abstract&pid=S2631-25812019000100010&lng=es&nrm=iso

2. Castillo J, Luna A, Rodríguez-Yáñez M, Ugarriza I, Zarranz JJ. Enfermedades vasculares cerebrales. En: Zarranz JJ. Neurología Sexta edición. Elsevier: España, [internet] 2018 [citado 13/12/2019]. Disponible en: https://inspectioncopy.elsevier.com/6/es/book/details/9788491130710

3. Suárez-Quesada A, Álvarez-Aliaga A, López-Espinosa E, Bárzaga-Morell S, Santisteban-García A. Pronóstico de muerte en pacientes con hemorragia intracerebral supratentorial espontánea. Revista Finlay [revista en Internet]. 2016 [citado 11/12/2019]; 6(1): [aprox. 8 p.]. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/408

4. Ropper AH, Samuels MA. Enfermedades Cerebrovasculares. En: Adams y Victor: Principios de Neurología. Parte IV. Capítulo 35. Décima Edición. McGraw-Hill: México; [internet] 2016 [citado 13/12/2019]. Disponible en:

https://es.slideshare.net/kevinarmijosm/adams-victor-principiosneurologiafororinconmedicotk

5. Chen S, Zhao B, Wang W, Shi L, Cesar Reis C, Zhang J. Predictors of hematoma expansion predictors after intracerebral hemorrhage. Oncotarget, [internet] 2017 [citado 13/12/2019]; 8(51): 89348-63. Disponible en: https://www.ncbi.nlm.nih.gov/m/pubmed/29179524&sa=U&ved=2ahUKEwi1-pat_PDoAhWNmuAKHcAgAvQQFjABegQIABAB&usg=AOvVaw0jYGj6VBAa_ki0KDf8Ys64

6. Øie LR, Mattis A, Madsbu, Solheim O, Asgeir S, Jakola, Giannadakis C, Vorhaug A, et al. Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population‐based study. Brain and Behavior. [internet] 2018 [citado 13/12/2019]; 8: e01113. Disponible en: https://dx.doi.org/10.1002/brb3.1113

7. Green L, Tan J, Morris JK, Alikhan R, Curry R, Everington T, et al. A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study). Haematol [internet] 2018 [citado 13/12/2019]; 103 (4): 738-745. Disponible en: http://www.doi:10.3324/haematol.2017.182220

8. Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. [internet] 2001 [citado 13/12/2019]; 32: 891-7. Disponible en: https://www.ncbi.nlm.nih.gov/m/pubmed/11283388&sa=U&ved=2ahUKEwiZ_LzK_PDoAhXCmeAKHcdXA0AQFjACegQICBAB&usg=AOvVaw0tAAlvTgKZn7qkHyTyku_N

9. Méndez Fleitas L, Carmona Denis Y, Moreno Peña LE, Escalona Robaina CR, Ortega Peñate JA. Caracterización clínica de la hemorragia intracerebral en pacientes ingresados en Hospital Faustino Pérez. 2012-2013. Rev Méd Electrón [Internet]. 2019 Ene-Feb [citado: 12/12/2019]; 41(1). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/2985/4172

10. Clarke JL, Johnston SC, Farrant M, Bernstein R, Tong D, Hemphill JC 3rd. External validation of the ICH score. Neurocrit Care [internet] 2004 [citado 13/12/2019]; 1(1): 53-60. Disponible en: http://neurocriticalcare.pbworks.com/f/ICH%2BScore%2Bvalidation%2Bpaper.pdf&sa=U&ved=2ahUKEwjU1JXw_PDoAhWLUt8KHecyC5QQFjAFegQIAxAB&usg=AOvVaw01VJGjKqnGNDwt-C9zeG9i

11. Aguilera Pacheco OR, González Vidal D. Factores pronósticos en la hemorragia cerebral intraparenquimatosa. MEDISAN (internet) 2012 (citado 13/12/2019); 16 (1): 21. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192012000100003

12. Pérez García AR, García Monter A, Sosa Acosta EF, Padrón Valdés F. Factores pronósticos de mortalidad por hemorragia intracerebral en el periodo agudo. Rev Cub de Medic Milit. [internet] 2015 [citado 13/12/2019]; 44 (3): 277-88. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572015000300002

13. Brito F, Correiras J, Neves D, Valdir E, Farias L, Ferreira R, et al. Hemorragia Intracerebral Espontánea Estudio retrospectivo de 72 casos operados. Arq Neuropsiquiatr [internet] 2000 [citado 13/12/2019]; 58(2-B): 499-504. Disponible en: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2000000300016

14. Safatli, D. A., Gunther, A., Schlattmann, P., Schwarz, F., Kalff, R., & Ewald, C. Predictors of 30‐day mortality in patients with spontaneous primary intracerebral hemorrhage. Surg Neurol International (internet) 2016 (citado 13/12/2019) 7 (Suppl. 18), S510–S517. Disponible en: https://dx.doi.org/10.4103/2152-7806.187493

15. Rahmani F, Rikhtegar R, Ala A, Farkhad-Rasooli A, Ebrahimi-Bakhtavar H. Predicting 30-day mortality in patients with primary intracerebral hemorrhage: Evaluation of the value of intracerebral hemorrhage and modified new intracerebral hemorrhage scores. Iran J Neurol [internet] 2018 [citado 13/12/2019]; 17(1): 47-52. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121209/

16. Li Q, Huang YJ, Zhang G, Lv FJ, Wei X, Dong MX, et al. Intraventricular hemorrhage and early hematoma expansion in patients with intracerebral hemorrhage. Scientific Reports. [internet] 2015 [citado 13/12/2019]; 5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471897/&sa=U&ved=2ahUKEwjiiNvw_vDoAhVvmeAKHfl8B1QQFjACegQICBAB&usg=AOvVaw2K36N-K0FJW7k2nIC7mn1f

17. Xia Zhou H, Hao N, Lin Xu N. Related factors of early mortality in young adults with cerebral hemorrhage. Open Med. (internet) 2018 (citado 12/12/2019); 13: 214-220. Disponible en: https://dx.doi.org/10.1515/med-2018-0033

Downloads

Published

2020-06-30

How to Cite

1.
Rodríguez-Venegas E de la C, Hernández-García OL, Denis-Piedra DA, Cabrera-Nicó A, Valdés-Blanco M. Prognostic factors of mortality rate in patients with spontaneous intracerebral hemorrhage. Rev Ciencias Médicas [Internet]. 2020 Jun. 30 [cited 2025 Aug. 26];24(4):e4440. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/4440

Issue

Vol. 24 No. 4 (2020)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/